Evidence map›Paper›PMID 29712689›Full record

ArticleBMJ open2018

A systematic analysis of UK cancer research funding by gender of primary investigator.

Charlie D Zhou, Michael G Head, Dominic C Marshall, Barnabas J Gilbert, Majd A El-Harasis, Rosalind Raine, Henrietta O'Connor, Rifat Atun, Mahiben Maruthappu

Abstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Women in cancer research.Nature reviews. Cancer · 2019
    Article
  10. Article
  11. Article
  12. Actionable equality.Nature medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Charlie D ZhouDepartment of Nuclear Medicine, Royal Free NHS Foundation Trust, London, UK.
Michael G HeadFaculty of Medicine, Institute for Life Sciences, Global Health Research Institute, University of Southampton, Southampton, UK.
Dominic C MarshallOxford University Clinical Academic Graduate School, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0002-3498-2511
Barnabas J GilbertDepartment of Economics, University of Oxford, Oxford, UK.
Majd A El-HarasisFaculty of Medicine, Imperial College London, London, UK.
Rosalind RaineDepartment of Applied Health Research, University College London, London, UK.
Henrietta O'ConnorSchool of Media, Communication and Sociology, University of Leicester, Leicester, UK.
Rifat Atun *Harvard T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Mahiben Maruthappu *Department of Epidemiology and Public Health, University College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo categorically describe cancer research funding in the UK by gender of primary investigator (PIs).

designSystematic analysis of all open-access data.

methodsData about public and philanthropic cancer research funding awarded to UK institutions between 2000 and 2013 were obtained from several sources. Fold differences were used to compare total investment, award number, mean and median award value between male and female PIs. Mann-Whitney U tests were performed to determine statistically significant associations between PI gender and median grant value.

resultsOf the studies included in our analysis, 2890 (69%) grants with a total value of £1.82 billion (78%) were awarded to male PIs compared with 1296 (31%) grants with a total value of £512 million (22%) awarded to female PIs. Male PIs received 1.3 times the median award value of their female counterparts (P<0.001). These apparent absolute and relative differences largely persisted regardless of subanalyses.

conclusionsWe demonstrate substantial differences in cancer research investment awarded by gender. Female PIs clearly and consistently receive less funding than their male counterparts in terms of total investment, the number of funded awards, mean funding awarded and median funding awarded.

Indexed as

Biomedical ResearchFemaleHumansMaleNeoplasmsResearch PersonnelSex FactorsSystems AnalysisUnited KingdomFundingGenderGlobal HealthResearch And DevelopmentResearch Investment

Identifiers

PMID29712689
PMCPMC5931297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.